Ovctek China, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002MR0
  • SHE: 300595
CNY
10.27
0.05 (0.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

8.24 M

Shareholding (Jun 2026)

FII

0.06%

Held by 1 FIIs

DII

99.94%

Held by 0 DIIs

Promoter

0.00%

iScoreScore

Dashboard

1

Flat results in Mar 26

  • OPERATING CASH FLOW(Y) Lowest at CNY 779.01 MM
  • ROCE(HY) Lowest at 9.39%
2

With ROE of 10.33%, it has a fair valuation with a 1.47 Price to Book Value

3

Majority shareholders : FIIs

 
4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 7,671 Million (Mid Cap)

stock-summary
P/E

18.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.19%

stock-summary
Debt Equity

-0.45

stock-summary
Return on Equity

10.33%

stock-summary
Price to Book

1.52

Revenue and Profits:
Net Sales:
406 Million
(Quarterly Results - Jun 2026)
Net Profit:
88 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.97%
0%
-7.97%
6 Months
-26.64%
0%
-26.64%
1 Year
-38.76%
0%
-38.76%
2 Years
-23.24%
0%
-23.24%
3 Years
-60.67%
0%
-60.67%
4 Years
-72.6%
0%
-72.6%
5 Years
-87.16%
0%
-87.16%

Ovctek China, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
11.82%
EBIT Growth (5y)
0.57%
EBIT to Interest (avg)
64.57
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
0.37
Tax Ratio
15.50%
Dividend Payout Ratio
35.10%
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
33.21%
ROE (avg)
19.66%

Valuation key factors

Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.83
EV to EBIT
13.11
EV to EBITDA
10.30
EV to Capital Employed
2.52
EV to Sales
3.79
PEG Ratio
NA
Dividend Yield
1.81%
ROCE (Latest)
19.24%
ROE (Latest)
10.33%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.06%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 3.39% vs -6.26% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -14.09% vs -29.71% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "405.80",
          "val2": "392.50",
          "chgp": "3.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "127.70",
          "val2": "144.40",
          "chgp": "-11.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.00",
          "val2": "3.80",
          "chgp": "-47.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "12.90",
          "val2": "6.40",
          "chgp": "101.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "87.80",
          "val2": "102.20",
          "chgp": "-14.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "202.40%",
          "val2": "253.50%",
          "chgp": "-5.11%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 2.68% vs 4.39% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -12.53% vs -14.71% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,849.80",
          "val2": "1,801.60",
          "chgp": "2.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "812.90",
          "val2": "835.20",
          "chgp": "-2.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "16.70",
          "val2": "15.60",
          "chgp": "7.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-57.60",
          "val2": "-33.40",
          "chgp": "-72.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "543.90",
          "val2": "621.80",
          "chgp": "-12.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "336.80%",
          "val2": "375.60%",
          "chgp": "-3.88%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - YoYstock-summary

Jun'26
Jun'25
Change(%)
Net Sales
405.80
392.50
3.39%
Operating Profit (PBDIT) excl Other Income
127.70
144.40
-11.57%
Interest
2.00
3.80
-47.37%
Exceptional Items
12.90
6.40
101.56%
Consolidate Net Profit
87.80
102.20
-14.09%
Operating Profit Margin (Excl OI)
202.40%
253.50%
-5.11%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2026 is 3.39% vs -6.26% in Jun 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2026 is -14.09% vs -29.71% in Jun 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,849.80
1,801.60
2.68%
Operating Profit (PBDIT) excl Other Income
812.90
835.20
-2.67%
Interest
16.70
15.60
7.05%
Exceptional Items
-57.60
-33.40
-72.46%
Consolidate Net Profit
543.90
621.80
-12.53%
Operating Profit Margin (Excl OI)
336.80%
375.60%
-3.88%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 2.68% vs 4.39% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -12.53% vs -14.71% in Dec 2024

stock-summaryCompany CV
About Ovctek China, Inc. stock-summary
stock-summary
Ovctek China, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Footer loading